doi: 10.5732/cjc.014.10117
TCGA divides gastric cancer into four molecular subtypes: implications for individualized therapeutics
Wei Zhang
Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
[Abstract] Gastric cancer is a leading cause of cancer deaths in the world. The treatment of gastric cancer is challenging because of its highly heterogeneous etiology and clinical characteristics. Recent genomic and molecular characterization of gastric cancer, especially the findings reported by the Cancer Genome Atlas (TCGA), have shed light on the heterogeneity and potential targeted therapeutics for four different subtypes of gastric cancer.
Chinese Journal of Cancer 2014, Volume: 33, Issue 10, Page: 469-470
[ PDF Full-text ]
[ Html full-text ](PubMed Central)
[ PubMed ]
[Google Scholar]
Cite this article
Wei Zhang. TCGA divides gastric cancer into four molecular subtypes: implications for individualized therapeutics. Chin J Cancer. 2014, 33(10):469-470. doi:10.5732/cjc.014.10117
Export citations
EndNote
[ Html full-text ](PubMed Central)
[ PubMed ]
[Google Scholar]
Cite this article
Wei Zhang. TCGA divides gastric cancer into four molecular subtypes: implications for individualized therapeutics. Chin J Cancer. 2014, 33(10):469-470. doi:10.5732/cjc.014.10117
Export citations
EndNote
SHARE THIS ARTICLE
Comments:
